Merck & Company Inc (MRK)
Total asset turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 64,168,000 | 60,115,000 | 59,283,000 | 48,704,000 | 41,518,000 |
Total assets | US$ in thousands | 117,106,000 | 106,675,000 | 109,160,000 | 105,694,000 | 91,588,000 |
Total asset turnover | 0.55 | 0.56 | 0.54 | 0.46 | 0.45 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $64,168,000K ÷ $117,106,000K
= 0.55
The total asset turnover of Merck & Company Inc has shown an upward trend over the past five years, increasing from 0.45 in December 31, 2020 to 0.55 in December 31, 2024. This indicates that the company has become more efficient in generating sales relative to its total assets. The improvement in total asset turnover suggests that Merck & Company Inc has been able to better utilize its assets to drive revenue growth, which is a positive sign for the company's operational efficiency and profitability.
Peer comparison
Dec 31, 2024
Company name
Symbol
Total asset turnover
Merck & Company Inc
MRK
0.55
Abbott Laboratories
ABT
0.54
AbbVie Inc
ABBV
0.40
Alkermes Plc
ALKS
0.76
Amphastar P
AMPH
0.46
ANI Pharmaceuticals Inc
ANIP
0.50
Arcus Biosciences Inc
RCUS
0.22
Biomarin Pharmaceutical Inc
BMRN
0.41
Bristol-Myers Squibb Company
BMY
0.52
Catalent Inc
CTLT
0.45
Catalyst Pharmaceuticals Inc
CPRX
0.85